Calcium dysregulation in relation to A lzheimer‐type pathology in the ageing brain
Open accessAbstract
Aims: Calcium dyshomeostasis is implicated in the pathogenesis of several neurodegenerative disorders including A lzheimer's disease. However, much of the previous research has focused on changes in neuronal calcium signalling. In a recent microarray study we identified dysregulation of several key signalling pathways including the Ca2+ signalling pathway in astrocytes as A lzheimer‐type pathology developed. In this study we sought to determine the expression of calpain‐10 and calcium/calmodulin‐dependent kinase alpha (CamKII α) in relation to A lzheimer‐type pathology in a population‐based study. Methods: Using post mortem temporal cortex samples derived from the M edical R esearch C ouncil C ognitive F unction and A geing St udy (MRC‐CFAS) ageing brain cohort we examined calpain‐10 and CamKII α gene and protein expression using quantitative polymerase chain reaction and immunohistochemistry. Results: We demonstrate that astrocytic expression of calpain‐10 is up‐regulated, and CamKIIα down‐regulated with increasing B raak stage. Using immunohistochemistry we confirm protein expression of calpain‐10 in astrocytes throughout the temporal cortex and demonstrate that calpain‐10 immunoreactivity is correlated with both local and global measures of A lzheimer‐type pathology. In addition, we identify a subpopulation of calpain‐10 immunoreactive interlaminar astrocytes that extend processes deep into the cortex. CamKII α is predominantly neuronal in localization and is associated with the presence of diffuse plaques in the ageing brain. Discussion: Dysregulated expression of key calcium signalling molecules occurs with progression of A lzheimer‐type pathology in the ageing brain, highlighting the need for further functional studies of astrocytic calcium signalling with respect to disease progression.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
An aberrant increase in Calpain-10 protein and a reduction of CamKII correlates with Alzheimer's disease progression, particularly in ILAs.
“An aberrant increase in Calpain-10 protein (a protease involved in Ca2+ homeostasis) and a reduction of CamKII (a Ca2+ signaling kinase) correlates with disease progression, particularly in ILAs (Garwood et al., 2013).”
From Interlaminar and varicose-projection astrocytes: toward a new understanding of the primate brain (2024) · cites this paper as Garwood et al., 2013
Evidence of Ca2+ signaling disruption in Alzheimer's disease early stages has been observed in both neurons and astrocytes, even before the appearance of typical cognitive decline.
“Evidence of Ca2+ signaling disruption in AD’s early stages has been observed in both neurons and astrocytes, even before the appearance of the typical cognitive decline (Garwood et al., 2013).”
From Interlaminar and varicose-projection astrocytes: toward a new understanding of the primate brain (2024) · cites this paper as Garwood et al., 2013
Cites
Alzheimer neuropathologic alterations in aged cognitively normal subjects
Davis, D. G., Schmitt, F. A., Wekstein, D. R., & Markesbery, W. R. (1999) · Journal of Neuropathology and Experimental Neurology · doi:10.1097/00005072-199904000-00008 · Cited by 516 · cited 1× · see citing works
“However, population-based neuropathological studies have found that Alzheimer-type pathology is not unique to clinically defined AD, but may be found in ageing brains from individuals without dementia and there is considerable overlap in burdens of Alzheimer-type pathology between demented and nondemented individuals…”
Reactive Glia not only Associates with Plaques but also Parallels Tangles in Alzheimer’s Disease
Serrano-Pozo, A., Mielke, M. L., Gómez-Isla, T., Betensky, R. A., Growdon, J. H., Frosch, M. P., & Hyman, B. T. (2011) · The American Journal of Pathology · doi:10.1016/j.ajpath.2011.05.047 · Cited by 488 · see citing works
Changing perspectives regarding late-life dementia
Fotuhi, M., Hachinski, V., & Whitehouse, P. J. (2009) · Nature Reviews Neurology · doi:10.1038/nrneurol.2009.175 · Cited by 291 · see citing works
Flagged first, then by citations
Cited by
Sorted by citations
Garwood, C. J., Ratcliffe, L. E., Simpson, J. E., Heath, P. R., Ince, P. G., & Wharton, S. B. (2017) · Neuropathology and Applied Neurobiology · doi:10.1111/nan.12338 · Cited by 233 · see citing works
Self-citationGarwood, C. J., Ratcliffe, L. E., Morgan, S. V., Simpson, J. E., Owens, H., Vazquez-Villaseñor, I., Heath, P. R., Romero, I. A., Ince, P. G., & Wharton, S. B. (2015) · Molecular Brain · doi:10.1186/s13041-015-0138-6 · Cited by 101 · see citing works
Self-citationInterlaminar and varicose-projection astrocytes: toward a new understanding of the primate brain
Ciani, C., & Falcone, C. (2024) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2024.1477753 · Cited by 11 · see citing works
- Authors
- Garwood, C., Faizullabhoy, A., Wharton, S. B., Ince, P. G., Heath, P. R., Shaw, P. J., Baxter, L., Gelsthorpe, C., Forster, G., Matthews, F. E., Brayne, C., Simpson, J. E., & MRC Cognitive Function and Ageing Neuropathology Study Group
- Affiliations
- University of Sheffield (GB)
- MRC Biostatistics Unit (GB)
- University of Cambridge (GB)
- Corresponding author
- Simpson, J. E.
- ORCID
- Venue
- Neuropathology and Applied Neurobiology
- Publisher
- Wiley
- Published
- 2013-10-29
- Volume
- 39
- Issue
- 7
- Pages
- 788-799
- ISSN
- 0305-1846 (ISSN-L)
- 1365-2990
- OpenAlex
- W2105203043
- Cited by
- 47
- References
- 3
- Citations by year
- 2026: 1 · 2025: 2 · 2024: 2 · 2023: 1 · 2022: 3 · 2021: 3 · 2019: 5 · 2018: 4 · 2017: 4 · 2016: 6 · 2015: 9 · 2014: 4 · 2013: 3
- FWCI
- 5.09
- Type
- journal article
- Language
- en
- Open access
- Locations
- Neuropathology and Applied Neurobiology (publishedVersion)
- PubMed (publishedVersion)
- Repository@Hull (Worktribe) (University of Hull) (submittedVersion, cc-by)
- Funders
- National Institute for Health and Care Research (NF-SI-0611-10084)
- Medical Research Council (MR/J004308/1, MR/L022656/1, MR/L016451/1)
- Topics
- Health Sciences › Medicine › Physiology › Alzheimer's disease research and treatments
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Calpain Protease Function and Regulation
- Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
- Keywords
- calcium dysregulation, Alzheimer's disease, astrocytes, CAPN10, CaMKIIα, Braak stages, amyloid plaques, temporal cortex, brain aging, gene expression
- MeSH terms
- Adolescent, Adult, Aging, Alzheimer Disease, Astrocytes, Brain, Calcium, Child, Female, Humans, Male, Middle Aged, Neurons, Young Adult, Plaque, Amyloid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review